Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Lymphoblastic Leukemia
100%
Relapse Risk
100%
Pharmacogenomics
100%
Childhood Acute Lymphoblastic Leukemia
66%
Ethnic Differences
66%
Germ Cells
33%
Native American
33%
Chemotherapy
33%
African American
33%
European American
33%
Prognostic Factors
33%
Hispanic Ethnicity
33%
Large Cohort
33%
Poor Survival
33%
5-year Survival
33%
Genomic Variation
33%
Non-genetic Factors
33%
P Factor
33%
Extra Phase
33%
SNP Genotyping
33%
Over 80
33%
Biochemistry, Genetics and Molecular Biology
Single Nucleotide Polymorphism
100%
Germline
100%
Germ Cell
100%
Genetics
100%
Genetic Determinism
100%
Pharmacogenomics
100%
Survival Rate
100%
Genomics
100%
Immunology and Microbiology
Single Nucleotide Polymorphism
100%
Pharmacogenomics
100%
Heredity
100%
Survival Rate
100%
Germ Cell
100%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Pharmacogenomics
100%
Single Nucleotide Polymorphism
25%
Prognostic Factor
25%
Five-Year Survival Rate
25%
Heredity
25%
Chemotherapy
25%
Germ Cell
25%